CMAJ/JAMC Special supplement
Supplément spécial

Table 1: Summary of survival and recurrence in prospective randomized trials of mastectomy versus breast-conserving surgery
 
Study groupInterventionsNo. of patientsFollow-up; yrSurvival; %Disease-free survival; %Local recurrence; %

Veronesi et al (Milan), 19907BCS + RT
TM
352
349
15
15
68
66

3.3
2.3

Fisher et al (NSABP), 19893BCS
BCS + RT
TM
636
629
590
8
8
8
83
84
82
64
71
67
39
10
8

Blichert-Toft et al (Denmark), 19922BCS + RT
TM
430
429
6
6
79
82
70
66


van Dongen et al (EORTC), 19925BCS + RT
TM
426
456
8
8
60
60

11
8

Jacobson et al (NCI), 19958BCS + RT
TM
121
116
10
10
77
75
72
69
5
10

Arriagada et al (Institut Gustave-Roussy), 19961BCS + RT
TM
88
91
15
15
73
65
55
44
9
14

NSABP = National Surgical Adjuvant Breast Project, NCI = National Cancer Institute, EORTC = European Organization for the Research and Treatment of Cancer, BCS = breast-conserving surgery, RT = radiotherapy, TM = total mastectomy


Return to Guideline 3